WUXI, China, Oct. 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP ...

Opportunities arise from enhancing GMP audit processes through effective communication, conflict resolution, and compliance risk management. Training improves relationships, identifies compliance gaps ...

SUZHOU, China, May 21, 2025 /PRNewswire/ -- BioDlink has achieved a significant milestone in regulatory compliance after successfully passing an on-site GMP inspection conducted by Brazil's National ...

The success of virtual GMP inspections performed during the pandemic may lead to more flexible opportunities in the future. A temporary system, under which good manufacturing practice (GMP) ...

It is very important for pharmaceutical companies to plan carefully for all Good Manufacturing Practice (GMP) inspections, as a successful outcome is required for continued operations. Careful ...

Shardul Nautiyal, Mumbai Thursday, February 19, 2026, 08:00 Hrs [IST] ...

WUXI, China, April 6, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully ...

SHANGHAI, China, Feb. 23 /PRNewswire-Asia/ -- WuXi PharmaTech ( WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China ...

Indian medical device manufacturers are enhancing their Good Manufacturing Practice (GMP) compliance, reinforcing India's role as a trusted global supplier in the healthcare and MedTech sectors. This ...